Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Board/Management Information 2024

May 2, 2024

62222_rns_2024-05-02_e9c242dc-fa1b-46d8-aee0-6ebced8c64a8.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [596 x 111] intentionally omitted <==

2 May 2024

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai 400 051

Scrip Code: 524669

Symbol: HESTERBIO

Dear Sir / Madam:

Subject: Intimation for the Board Meeting

This is to inform you that, as per Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time), a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 10 May 2024, inter alia, to consider the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2024, and to consider the declaration of dividend, if any, on the equity shares of the Company for the financial year 2023-24.

We request you to take note of the above.

Sincerely

For Hester Biosciences Limited

Vinod Digitally signed by Vinod Mali Date: Mali 2024.05.02 18:43:14 +05'30'

Vinod Mali

Company Secretary & Compliance Officer